{"id":782363,"date":"2026-05-08T16:58:26","date_gmt":"2026-05-08T16:58:26","guid":{"rendered":"https:\/\/www.europesays.com\/us\/782363\/"},"modified":"2026-05-08T16:58:26","modified_gmt":"2026-05-08T16:58:26","slug":"womans-arms-and-legs-turn-blue-after-taking-common-drug","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/782363\/","title":{"rendered":"Woman&#8217;s arms and legs turn blue after taking common drug"},"content":{"rendered":"<p>Willy Wonka\u2019s Violet Beauregarde could start a support group.<\/p>\n<p>According to a case report in the <a href=\"https:\/\/www.nejm.org\/doi\/10.1056\/NEJMicm2513782\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">New England Journal of Medicine<\/a>, a 68-year-old woman developed \u201cblue-gray\u00a0hyperpigmentation\u201d on her limbs just a couple of weeks after she started taking a common medication.<\/p>\n<p>The woman sought treatment after dark patches on her arms and legs persisted for six weeks.  <\/p>\n<p><img style=\"aspect-ratio:1.50146628;display:block\" loading=\"lazy\" decoding=\"async\" data-modal-image=\"39319030\" width=\"886\" height=\"590\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2026\/05\/127252420.jpg\" alt=\"Collage of a patient's forearms and legs with confluent erythematous papules and plaques.\" class=\"wp-image-39319030\"  \/>Prior to the dark development, the woman, who suffers from rosacea, a common skin condition that causes the face to appear red or flushed, began taking 100 mg daily of oral\u00a0minocycline. <\/p>\n<p>The woman suffers from rosacea, a common skin condition that causes the face to appear red or flushed \u2014 and wasn\u2019t the cause of the blue hue.<\/p>\n<p>\u201cRosacea\u00a0is a chronic inflammatory condition in which the skin appears inflamed along with evidence of acne-like bumps and textural change,\u201d dermatologist\u00a0<a href=\"https:\/\/surfacedeep.com\/pages\/meet-dr-alicia-zalka\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Alicia Zalka<\/a> previously told The Post.<\/p>\n<p>\u201cBecause the condition is multifaceted and is the result of the interplay of genetics, environment, vascular inflammatory responses of the skin, and even skin mites, there is no single cause of rosacea and similarly no single treatment,\u201d she continued. <\/p>\n<p>To treat it, she began taking 100 mg daily of oral\u00a0minocycline two weeks prior.<\/p>\n<p>According to the <a href=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/minocycline-oral-route\/description\/drg-20075715\" target=\"_blank\" rel=\"noopener nofollow\">Mayo Clinic<\/a>, minocycline, a tetracycline antibiotic that kills bacteria or prevents their growth, is commonly prescribed to treat the acne-like bumps associated with rosacea. <\/p>\n<p>The drug \u2014 which is sold under brand names including Dynacin, Minocin and Solodyn \u2014\u00a0is widely prescribed to fight several conditions including acne and bacterial infections, like those that cause pneumonia.<\/p>\n<p>A <a href=\"https:\/\/nypost.com\/2026\/05\/05\/health\/this-surprising-drug-may-soon-be-used-to-treat-panic-disorder\/\" rel=\"nofollow noopener\" target=\"_blank\">recent study<\/a> found that it may also be helpful in treating panic disorder in patients who don\u2019t respond to psychiatric medications, including benzodiazepines like clonazepam.<\/p>\n<p>Minocycline\u2019s side effects include dizziness, GI issues like nausea, headache, fatigue and skin sensitivity. <\/p>\n<p><img style=\"aspect-ratio:1.06334372;display:block\" loading=\"lazy\" decoding=\"async\" data-modal-image=\"39319025\" width=\"627\" height=\"590\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2026\/05\/womans-arms-legs-turn-blue-127252161.jpg\" alt=\"Collage of a woman's arms and legs exhibiting blue-gray discoloration due to medication.\" class=\"wp-image-39319025\"  \/> After six months, the hyperpigmentation had \u201cabated somewhat\u201d but had not completely faded, as seen in the before-and-after photos.  The New England Journal of Medicine<\/p>\n<p>But hyperpigmentation \u2014 which can cause the skin to turn blue-grey or blue-black \u2014 is rare, impacting only affects 3-15% of patients. And it typically develops over months of treatment, not weeks.<\/p>\n<p>For this woman, the dark patches were initially isolated to her legs and described as \u201casymptomatic.\u201d<\/p>\n<p>It ultimately presented on her forearms and the sides of her tongue as well, leading to a diagnosis of \u201cminocycline-induced hyperpigmentation.\u201d<\/p>\n<p>Medical staff urged the woman to stop taking the medication and avoid sun exposure. After six months, the hyperpigmentation had \u201cabated somewhat\u201d but had not faded completely. <\/p>\n<p>While the woman was diagnosed with Type II minocycline-induced hyperpigmentation, in which the skin turns blue or gray, there are three additional types. <\/p>\n<p>For patients with Type I, blue-black spots appear in scar tissue, for those with Type III, muddy brown spots develop in areas of the skin exposed to sunlight, and for those with Type IV, these muddy brown spots appear in scar tissue.<\/p>\n<p>Experts maintain that patients should be warned of the risk of these skin changes, which can necessitate laser treatments to remove. <\/p>\n<p>In addition to the hyperpigmentation described above, minocycline can cause other serious skin reactions, including erythema multiforme and <a href=\"https:\/\/nypost.com\/2024\/05\/06\/health\/woman-develops-stevens-johnson-syndrome-after-taking-drug-for-depression\/\" rel=\"nofollow noopener\" target=\"_blank\">Stevens-Johnson syndrome (SJS)<\/a>, a rare disorder that begins with flu-like symptoms followed by a rash that blisters and spreads. <\/p>\n<p>The condition is fatal in 10% of patients.<\/p>\n<p>Minocycline has been used in humans for more than 50 years and is generally considered safe.<\/p>\n","protected":false},"excerpt":{"rendered":"Willy Wonka\u2019s Violet Beauregarde could start a support group. According to a case report in the New England&hellip;\n","protected":false},"author":3,"featured_media":782364,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[210,1141,1142,29884,6724,67,132,68,39590],"class_list":{"0":"post-782363","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-care","8":"tag-health","9":"tag-health-care","10":"tag-healthcare","11":"tag-skin","12":"tag-skincare","13":"tag-united-states","14":"tag-unitedstates","15":"tag-us","16":"tag-weird-but-true"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116540022882324882","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/782363","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=782363"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/782363\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/782364"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=782363"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=782363"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=782363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}